When monitoring time-dependent activation and maximal accumulation of activated p-Iκkβ and p-Iκbα targeted for degradation we noted that a more robust activation of the Nfκb pathway is associated with a marked decrease in susceptibility to CRC. The gene discussed is NFKBIA; the disease is colorectal carcinoma.